MHRA guidance and publications on a possible no deal scenario

Government publishes Information about the regulation of medicines and medical devices if the UK leaves the EU with no deal.

This information hasb een published on the website and can be found here:


Leaving the EU with a deal remains the Government’s top priority. This has not changed. However a responsible government must plan for every eventuality, including a no deal scenario.

The Agency is publishing a series of guidance documents for industry and other stakeholders covering our proposed arrangements for the regulation of medicines, medical devices and clinical trials, if we leave the EU with no deal.

We will add further links to this page as new guidance and information is published.

< Back to all blog articles